Laxmi Dental Ltd
Incorporated in 2004, Laxmi Dental is an integrated dental products company offering a comprehensive portfolio of Dental Products[1]
- Market Cap ₹ 1,370 Cr.
- Current Price ₹ 249
- High / Low ₹ 510 / 156
- Stock P/E 41.0
- Book Value ₹ 44.3
- Dividend Yield 0.00 %
- ROCE 14.9 %
- ROE 14.8 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 103% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Working capital days have increased from 77.3 days to 195 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 150 | 92 | 137 | 162 | 194 | 239 | 278 | |
| 146 | 88 | 130 | 152 | 169 | 196 | 234 | |
| Operating Profit | 3 | 4 | 7 | 9 | 24 | 43 | 43 |
| OPM % | 2% | 5% | 5% | 6% | 13% | 18% | 16% |
| 2 | 0 | -10 | 2 | 0 | 10 | 3 | |
| Interest | 3 | 3 | 4 | 4 | 6 | 6 | 1 |
| Depreciation | 7 | 6 | 8 | 11 | 12 | 15 | 16 |
| Profit before tax | -4 | -4 | -16 | -5 | 7 | 31 | 29 |
| Tax % | 5% | 8% | 15% | 4% | -136% | 21% | 9% |
| -5 | -5 | -19 | -4 | 25 | 32 | 29 | |
| EPS in Rs | -154.92 | -156.22 | -596.62 | -128.94 | 804.81 | 5.78 | 5.27 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 20% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 103% |
| 3 Years: | 124% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -37% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 23% |
| Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 11 | 11 |
| Reserves | 37 | 33 | 9 | 6 | 31 | 198 | 232 |
| 37 | 39 | 50 | 50 | 61 | 20 | 13 | |
| 31 | 34 | 43 | 40 | 46 | 60 | 38 | |
| Total Liabilities | 106 | 106 | 103 | 97 | 139 | 288 | 294 |
| 39 | 42 | 40 | 40 | 46 | 51 | 63 | |
| CWIP | 0 | 7 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 6 | 10 | 27 |
| 66 | 56 | 63 | 56 | 87 | 227 | 204 | |
| Total Assets | 106 | 106 | 103 | 97 | 139 | 288 | 294 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 12 | 10 | -2 | 14 | 8 | 44 | -5 | |
| -18 | -9 | 3 | -10 | -11 | -29 | -80 | |
| 6 | -0 | -4 | -1 | -3 | 111 | -18 | |
| Net Cash Flow | 0 | 0 | -3 | 3 | -5 | 125 | -102 |
| Free Cash Flow | -5 | 0 | -0 | 5 | -5 | 28 | -23 |
| CFO/OP | 357% | 226% | -30% | 157% | 38% | 109% | 4% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 64 | 54 | 46 | 47 | 56 | 60 |
| Inventory Days | 186 | 305 | 272 | 212 | 397 | 97 | |
| Days Payable | 197 | 273 | 245 | 197 | 585 | 47 | |
| Cash Conversion Cycle | 54 | 96 | 81 | 61 | 47 | -132 | 109 |
| Working Capital Days | 13 | 3 | -3 | -13 | 0 | 37 | 195 |
| ROCE % | 3% | -1% | 1% | 18% | 19% | 15% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Digital Units Penetration - Domestic Lab % |
|
|||
| Digital Units Penetration - International Lab % |
||||
| Domestic Lab Metal-Free Revenue Share % |
||||
| Aligner Solutions Total Cases Cases |
||||
| Dental Network Size Number (Dentists/Clinics) |
||||
| Domestic Lab Units Sold Units |
||||
| Employee Strength Count |
||||
| International Lab Units Sold Units |
||||
| Pediatric (Kids-E-Dental) Units Sold Units |
||||
| Intraoral Scanners Deployed Units |
||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7h - Extract of newspaper advertisements published on May 23, 2026, in the Financial Express (English Newspaper) and Mumbai Lakshdeep (Marathi Newspaper), with respect to Audited Standalone …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Q4FY26 earnings conference call audio recording uploaded on May 22, 2026.
- Announcement under Regulation 30 (LODR)-Investor Presentation 1d
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - Laxmi Dental reported Q4 FY26 revenue of ₹74.0 crore, FY26 revenue ₹277.9 crore, PAT ₹28.9 crore.
-
Results - Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026
1d - Board approved audited standalone and consolidated results for quarter and year ended 31 March 2026; unmodified opinion.
Concalls
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Feb 2025TranscriptAI SummaryPPT
Leading Dental Company[1]
Laxmi Dental is India’s only end-to-end integrated dental products company, operating across the full dental value chain — dental laboratory services, clear aligners, aligner materials & machines, and paediatric dental products. It is the second-largest domestic dental lab player and the largest Indian export dental laboratory